Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Irving

Showing results (161-170 of 563) with videos related to

Pageof 57
Sort By:
Alimentary Pharmacology & Therapeutics|August 22, 2022
Review article: guide to tofacitinib dosing in patients with ulcerative colitisPeter M Irving, Yvette Leung, Marla C Dubinsky
World Journal of Gastroenterology|November 4, 2015
How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?Mark G Ward, Peter M Irving, Miles P Sparrow
International Journal of Pediatric Otorhinolaryngology|December 1, 1993
Posterior glottic stenosis in childrenR M Irving, C M Bailey, J N Evans
Bio/Technology (Nature Publishing Company)|September 1, 1993
A reverse transcriptase-polymerase chain reaction assay for the detection and quantitation of murine retrovirusesJ M Irving, L W Chang, F J Castillo
Journal of American College Health : J of ACH|July 1, 1993
Health services at large public institutions: funding, utilization, and staffingM L Kunz, W M Irving, D R Black
Child Abuse & Neglect|March 1, 1993
The relationship between childhood sexual abuse and subsequent onset of bulimia nervosaD A Miller, K McCluskey-Fawcett, L M Irving
Digestive Diseases and Sciences|August 25, 2020
Vedolizumab Dose Escalation: In for a Penny, in for a Pound?Robin J Dart, Peter M Irving, Mark A Samaan
The New Zealand Medical Journal|November 23, 1994
Motor vehicle occupant injuries in New Zealand children, 1981-90L M Irving, S W Marshall, R N Norton
Current Gastroenterology Reports|November 12, 2009
Optimizing conventional therapies for inflammatory bowel diseaseMiles P Sparrow, Peter M Irving, Stephen B Hanauer
Chemical Research in Toxicology|October 13, 2011
N-biotinyl-S-(1,2-dichlorovinyl)-L-cysteine sulfoxide as a potential model for S-(1,2-dichlorovinyl)-L-cysteine sulfoxide: characterization of stability and reactivity with glutathione and kidney proteins in vitroRoy M Irving, Mark S Brownfield, Adnan A Elfarra
Pageof 57

Showing results (161-170 of 563) with videos related to

Sort By:
Pageof 57
Alimentary Pharmacology & Therapeutics|August 22, 2022
Review article: guide to tofacitinib dosing in patients with ulcerative colitisPeter M Irving, Yvette Leung, Marla C Dubinsky
World Journal of Gastroenterology|November 4, 2015
How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?Mark G Ward, Peter M Irving, Miles P Sparrow
International Journal of Pediatric Otorhinolaryngology|December 1, 1993
Posterior glottic stenosis in childrenR M Irving, C M Bailey, J N Evans
Bio/Technology (Nature Publishing Company)|September 1, 1993
A reverse transcriptase-polymerase chain reaction assay for the detection and quantitation of murine retrovirusesJ M Irving, L W Chang, F J Castillo
Journal of American College Health : J of ACH|July 1, 1993
Health services at large public institutions: funding, utilization, and staffingM L Kunz, W M Irving, D R Black
Child Abuse & Neglect|March 1, 1993
The relationship between childhood sexual abuse and subsequent onset of bulimia nervosaD A Miller, K McCluskey-Fawcett, L M Irving
Digestive Diseases and Sciences|August 25, 2020
Vedolizumab Dose Escalation: In for a Penny, in for a Pound?Robin J Dart, Peter M Irving, Mark A Samaan
The New Zealand Medical Journal|November 23, 1994
Motor vehicle occupant injuries in New Zealand children, 1981-90L M Irving, S W Marshall, R N Norton
Current Gastroenterology Reports|November 12, 2009
Optimizing conventional therapies for inflammatory bowel diseaseMiles P Sparrow, Peter M Irving, Stephen B Hanauer
Chemical Research in Toxicology|October 13, 2011
N-biotinyl-S-(1,2-dichlorovinyl)-L-cysteine sulfoxide as a potential model for S-(1,2-dichlorovinyl)-L-cysteine sulfoxide: characterization of stability and reactivity with glutathione and kidney proteins in vitroRoy M Irving, Mark S Brownfield, Adnan A Elfarra
Pageof 57